Qube Research & Technologies (QRT)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-160,523
| Closed | -$4.05M | – | 3978 |
|
|
2025
Q3 | $4.09M | Buy |
+160,523
| New | +$3.96M | ﹤0.01% | 1875 |
|
|
2025
Q2 | – | Sell |
-10,711,578
| Closed | -$250M | – | 3874 |
|
|
2025
Q1 | $271M | Buy |
+10,711,578
| New | +$280M | 0.31% | 65 |
|
|
2024
Q4 | – | Sell |
-1,151,891
| Closed | -$31.2M | – | 3747 |
|
|
2024
Q3 | $33.3M | Buy |
1,151,891
+1,127,162
| +4,558% | +$32.9M | 0.05% | 473 |
|
|
2024
Q2 | $692K | Sell |
24,729
-4,666,112
| -99% | -$128M | ﹤0.01% | 2031 |
|
|
2024
Q1 | $130M | Buy |
4,690,841
+3,411,743
| +267% | +$94.7M | 0.21% | 111 |
|
|
2023
Q4 | $36.8M | Buy |
1,279,098
+169,012
| +15% | +$5.11M | 0.07% | 334 |
|
|
2023
Q3 | $36.8M | Buy |
1,110,086
+362,717
| +49% | +$12.8M | 0.1% | 260 |
|
|
2023
Q2 | $27.4M | Sell |
747,369
-711,273
| -49% | -$27.7M | 0.1% | 271 |
|
|
2023
Q1 | $59.5M | Buy |
1,458,642
+1,396,976
| +2,265% | +$60.3M | 0.26% | 63 |
|
|
2022
Q4 | $3.16M | Sell |
61,666
-964,039
| -94% | -$46.2M | 0.02% | 786 |
|
|
2022
Q3 | $44.9M | Buy |
+1,025,705
| New | +$49.8M | 0.27% | 83 |
|
|
2022
Q2 | – | Sell |
-1,227,560
| Closed | -$63.6M | – | 2978 |
|
|
2022
Q1 | $63.6M | Buy |
1,227,560
+1,083,046
| +749% | +$56.2M | 0.54% | 15 |
|
|
2021
Q4 | $8.53M | Sell |
144,514
-576,163
| -80% | -$28.5M | 0.07% | 391 |
|
|
2021
Q3 | $31M | Buy |
720,677
+387,877
| +117% | +$17.2M | 0.39% | 42 |
|
|
2021
Q2 | $13M | Buy |
332,800
+163,692
| +97% | +$6.37M | 0.15% | 155 |
|
|
2021
Q1 | $6.13M | Sell |
169,108
-1,046,035
| -86% | -$37.1M | 0.1% | 260 |
|
|
2020
Q4 | $44.7M | Buy |
1,215,143
+842,041
| +226% | +$30.9M | 0.64% | 15 |
|
|
2020
Q3 | $13M | Buy |
373,102
+272,778
| +272% | +$9.56M | 0.19% | 122 |
|
|
2020
Q2 | $3.11M | Buy |
+100,324
| New | +$3.41M | 0.05% | 508 |
|
|
2020
Q1 | – | Sell |
-28,830
| Closed | -$1.07M | – | 1520 |
|
|
2019
Q4 | $1.07M | Buy |
+28,830
| New | +$1.03M | 0.03% | 580 |
|
|
2019
Q3 | – | Sell |
-69,474
| Closed | -$2.85M | – | 402 |
|
|
2019
Q2 | $2.85M | Sell |
69,474
-120,704
| -63% | -$4.79M | 0.68% | 30 |
|
|
2019
Q1 | $7.66M | Buy |
190,178
+176,542
| +1,295% | +$7.07M | 1.01% | 21 |
|
|
2018
Q4 | $565K | Sell |
13,636
-123,362
| -90% | -$5.12M | 0.24% | 103 |
|
|
2018
Q3 | $5.73M | Buy |
+136,998
| New | +$5.27M | 0.76% | 31 |
|
|
2018
Q2 | – | Sell |
-9,582
| Closed | -$322K | – | 902 |
|
|
2018
Q1 | $322K | Buy |
+9,582
| New | +$329K | 0.12% | 102 |
|
Other funds holding PFE
VCM
VPM
Qube Research & Technologies (QRT)'s PFE Position: Q4 2025 in Review
Qube Research & Technologies (QRT) sold out of Pfizer (PFE) in Q4 2025, closing a stake of 160,523 shares — an estimated $4.05M sold.
Qube Research & Technologies (QRT) first reported a position in PFE in Q1 2018 and held it in 25 quarters. The position peaked at $271M in Q1 2025. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Qube Research & Technologies (QRT) reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
- Qube Research & Technologies (QRT) sold 160,523 Pfizer shares in Q4 2025, an estimated $4.05M.
- Qube Research & Technologies (QRT) first reported a position in Pfizer in Q1 2018 and held it in 25 quarters.
- Qube Research & Technologies (QRT)'s Pfizer position peaked at $271M in Q1 2025.
- 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.